Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
4
×
fda
4
×
life sciences
national blog main
san francisco blog main
clinical trials
deals
national top stories
san francisco top stories
akouos
auris health
boston blog main
intuitive surgical
johnson & johnson
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roboticsai
abbvie
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
ashley mcevoy
aspire capital fund
astellas pharmaceuticals
astrazeneca
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer
cancer immunotherapy
cerovene
What
plans
4
×
cash
deal
fda
ipo
medical
medicines
acquiring
acquisitions
affects
americans
announced
approved
auris
billion
bio
builds
buy
ceo
clearance
collabs
company
company’s
covid
crunch
daniel
date
developer
developing
didn’t
drug
end
frequency
gilead
gilead’s
goal
health
hearing
help
introduce
Language
unset
Current search:
plans
×
biotech
×
photo
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B